Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

Goldman-Backed Biotech Attovia Raises $289 Million in US IPO

Bloomberg

BusinessBloomberg·Aug 5, 2026·1 min read

Goldman-Backed Biotech Attovia Raises $289 Million in US IPO

Attovia Therapeutics Inc., an early-stage drug developer focused on immune system diseases with high unmet need, raised $289 million in a US initial public offering that priced at the top of its marketed range.

View original source — Bloomberg ↗

ShareShare on X Share on Facebook

Related stories

China’s AI Agent Unicorn Lovart Is Said to Explore Hong Kong IPO

BusinessAug 5, 2026 · 1 min

China’s AI Agent Unicorn Lovart Is Said to Explore Hong Kong IPO

SK Hynix Climbs as Investors Bet on Shareholder Return Plan

BusinessAug 5, 2026 · 1 min

SK Hynix Climbs as Investors Bet on Shareholder Return Plan

LIC’s Big Share Sale Draws Investors Even as India’s IPO Market Stalls

BusinessAug 5, 2026 · 1 min

LIC’s Big Share Sale Draws Investors Even as India’s IPO Market Stalls

Why Japan is propping up the Yen with US help

BusinessAug 5, 2026 · 1 min

Why Japan is propping up the Yen with US help